# Laia Curto‐Barredo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laia-curto-barredo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,105 |
| Field | Urticaria and Related Conditions |
| h-index | 18 |
| i10-index | 33 |
| Last Known Institution | Universitat Autònoma de Barcelona |
| OpenAlex ID | https://openalex.org/A5027126202 |
| ORCID iD | 0000-0002-7387-4257 |
| Works | 69 |

## Researcher papers

- [Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment](https://scholariq.org/papers/clinical-features-of-chronic-spontaneous-urticaria-that-predict-disease/)
- [Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy](https://scholariq.org/papers/basophil-fc-ri-expression-in-chronic-spontaneous-urticaria-a-potential/)
- [Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria](https://scholariq.org/papers/omalizumab-updosing-allows-disease-activity-control-in-patients-with-refractory/)
- [Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease](https://scholariq.org/papers/basophil-activation-test-identifies-the-patients-with-chronic-spontaneous/)
- [Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort](https://scholariq.org/papers/acquired-cold-urticaria-clinical-features-particular-phenotypes-and-disease/)
- [Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria](https://scholariq.org/papers/rupatadine-20-mg-and-40-mg-are-effective-in-reducing-the-symptoms-of-chronic/)
- [Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series](https://scholariq.org/papers/treatment-of-moderate-to-severe-atopic-dermatitis-with-dupilumab-in-real/)
- [Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response](https://scholariq.org/papers/chronic-urticaria-phenotypes-clinical-differences-regarding-triggers-activity/)
- [Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement](https://scholariq.org/papers/transcriptome-analysis-of-severely-active-chronic-spontaneous-urticaria-shows-an/)
- [Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases](https://scholariq.org/papers/omalizumab-use-during-pregnancy-for-chronic-spontaneous-urticaria-csu-report-of/)
- [Patient Burden And Impact Of Moderate-to-Severe Atopic Dermatitis In the Spanish Healthcare System: The APOLO Cross-Sectional Study](https://scholariq.org/papers/patient-burden-and-impact-of-moderate-to-severe-atopic-dermatitis-in-the-spanish/)

## Researcher topics

- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

## Researcher university

- [Universitat Autònoma de Barcelona](https://scholariq.org/institutions/universitat-autonoma-de-barcelona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.